Αρχική World News EMA Recommends Granting a Marketing Authorisation for Ensartinib World News EMA Recommends Granting a Marketing Authorisation for Ensartinib Από Ogkologos - 9 Οκτωβρίου, 2026 482 0 Facebook Twitter Google+ Pinterest WhatsApp It is intended for the treatment of adult patients with ALK-positive, advanced NSCLC Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Ahead of the Special European Council Meeting on 26-27 November, ESMO Calls on EU Governments to Continue Support for the Cancer Mission European Parliament backs key priorities advocated by ESMO for cancer research and innovation FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer MOST POPULAR Disparities in Cancer Care Between Citizens and Refugees in Lebanon 23 Μαρτίου, 2021 A Remarkable Group of Patients with Haematological Disorders with No or... 15 Δεκεμβρίου, 2021 Whipple Procedure for Pancreatic Cancer: How to Prepare and What to... 16 Σεπτεμβρίου, 2021 Learning From Being Lost 14 Ιουλίου, 2021 Φόρτωση περισσοτέρων HOT NEWS The long road to targeting the holy grail of the immune... Pharmacy services are an untapped resource in tackling nation’s major health... FDA Approves Pembrolizumab with Chemotherapy for Biliary Tract Cancer Anticancer Drugs in the Adjuvant Setting Have Considerable Costs Per Event...